US 10961232
Substituted pyrazines as ATR kinase inhibitors
granted A61PA61P35/00
Quick answer
US patent 10961232 (Substituted pyrazines as ATR kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P35/00